bioMérieux S.A. BMXMF
102.14 USD 0.00 (+0.00%)
At closeNov 3, 2026, 4:00 PM EST
95.00 Day range 95.00
77.00 52-week range 132.05
- YTD
- -20.97%
- 1 year
- -18.51%
- Market cap
- 12.02B
- EPS (ttm)
- 4.55
- P/E ratio
- 22.45
- YTD return
- -20.97%
- 1-year return
- -18.51%
- Volume
- 105
- Avg volume
- 64
- Open
- 95.00
- Previous close
- 102.14
- Day's range
- 95.00 – 95.00
- 52-week range
- 77.00 – 132.05
- Earnings date
- Mar 4, 2027
2Y -5.61 (-5.21%)
Next earnings
Mar 4, 2027
Expected Mar 4, 2027. Consensus EPS estimate 2.93.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Mar 4, 2027 | Dec 30, 2026 | 2.93 | — | — | — |
| Jul 28, 2026 | Jun 30, 2026 | 2.32 | 2.27 | -0.05 | -2.16% |
| Feb 27, 2026 | Dec 31, 2025 | 2.50 | 2.35 | -0.15 | -6.00% |
| Sep 4, 2025 | Jun 30, 2025 | 2.55 | 1.59 | -0.96 | -37.65% |
| Mar 7, 2025 | Dec 31, 2024 | 2.23 | 1.91 | -0.32 | -14.35% |
| Sep 5, 2024 | Jun 30, 2024 | — | 1.95 | — | — |
News
bioMérieux S.A. (BMXXY) Q3 2026 Sales/Trading Call Transcript 
bioMerieux (OTCMKTS:BMXMF) Shares Gap Up – What’s Next? 
bioMerieux (OTCMKTS:BMXMF) Stock Now Rated “Reduce” by Sell-Side Analysts 
bioMérieux S.A. (BMXXY) Q1 2026 Sales/Trading Call Transcript 
Analyzing HealthEquity (NASDAQ:HQY) and bioMerieux (OTCMKTS:BMXMF) 
bioMerieux (OTCMKTS:BMXMF) Shares Gap Up – Time to Buy? 
bioMérieux S.A. (BMXXY) Q4 2025 Earnings Call Transcript 
bioMérieux S.A. (BMXXY) Analyst/Investor Day Transcript 
bioMérieux S.A. (BMXMF) Q4 2024 Earnings Call Transcript 
bioMérieux S.A. (BMXMF) Q2 2024 Earnings Call Transcript
Your note
Sign in to keep a note on BMXMF — it syncs with the Stock Master app.